Changes of microalbuminuria and serum high molecular weight-adiponectin in hypertensive patients with metabolic syndrome
Zhu Shi-ming
Abstract
Zhu Shi-ming
Abstract
Objective To compare the differences of microalbuminuria(MAU) and serum high molecular weight-adiponectin( HMW-ADP) between essential hypertensive patients and hypertensive patients with metabolic syndrome (MS),and to explore the association of MAU and HMW-ADP in hypertensive patients with MS. Methods 68 essential hypertensive patients were enrolled and divided into two groups by the definition of MS: the MS and hypertension group (n = 33) and the pure hypertension group (n = 35). The urine albumin-to-creatinine ratio(ACR) was measured by radioimmunoassay. Serum HMW-ADP was determined by sandwich ELISA. Results The MAU level was higher and the level of serum HMW-ADP was lower in the MS and hypertension group than in the hypertension group(P 0. 01). Pearson correlation analysis showed that HMW-ADP was not correlated with ACR(P 0. 05). Binary logistic regression showed that fasting plasma glucose,high density lipoprotein cholesterol,triglyceride,low density lipoprotein cholesterol,ACR and HMW-ADP were associated with the development of MS in hypertensive patients( P 0. 05-0. 01). Conclusions MS aggravates kidney damage in hypertensive patients. HMW-ADP is not correlated with ACR. Increase of ACR and decrease of HMW-ADP promote development of MS in patients with hypertension.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the differences of microalbuminuria(MAU) and serum high molecular weight-adiponectin( HMW-ADP) between essential hypertensive patients and hypertensive patients with metabolic syndrome (MS),and to explore the association of MAU and HMW-ADP in hypertensive patients with MS. Methods 68 essential hypertensive patients were enrolled and divided into two groups by the definition of MS: the MS and hypertension group (n = 33) and the pure hypertension group (n = 35). The urine albumin-to-creatinine ratio(ACR) was measured by radioimmunoassay. Serum HMW-ADP was determined by sandwich ELISA. Results The MAU level was higher and the level of serum HMW-ADP was lower in the MS and hypertension group than in the hypertension group(P 0. 01). Pearson correlation analysis showed that HMW-ADP was not correlated with ACR(P 0. 05). Binary logistic regression showed that fasting plasma glucose,high density lipoprotein cholesterol,triglyceride,low density lipoprotein cholesterol,ACR and HMW-ADP were associated with the development of MS in hypertensive patients( P 0. 05-0. 01). Conclusions MS aggravates kidney damage in hypertensive patients. HMW-ADP is not correlated with ACR. Increase of ACR and decrease of HMW-ADP promote development of MS in patients with hypertension.
Key concepts: Microalbuminuria, Internal medicine, Medicine, Endocrinology, Creatinine, Adiponectin, Triglyceride, Metabolic syndrome